SOLENO THERAPEUTICS INC (SLNO)
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Address
203 REDWOOD SHORES PARKWAY
REDWOOD CITY, CA 94065
Founded
1999
Number of Employees
42
Website
http://www.soleno.life
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)